Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
17.28
-0.72 (-4.00%)
At close: Jun 8, 2026, 4:00 PM EDT
17.28
0.00 (0.00%)
After-hours: Jun 8, 2026, 4:10 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $574.2 million as of June 8, 2026.
Market Cap
574.20M
Enterprise Value
405.52M
1-Year Change
n/a
Ranking
Category
Stock Price
$17.28
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $574.20M, an increase of 85.95%. That is a compound annual growth rate of 89.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 598.12M | 157.97% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 640.06M |
| Tenax Therapeutics | 631.76M |
| SpyGlass Pharma | 627.75M |
| Zevra Therapeutics | 627.21M |
| BridgeBio Oncology Therapeutics | 625.64M |
| Relmada Therapeutics | 624.10M |
| Candel Therapeutics | 623.53M |
| Aclaris Therapeutics | 608.93M |